The latest news from oncology events around the world
Welcome to Part 2 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.
Patients with advanced gastric or gastro-oesophageal junction (GEJ) cancer treated with CAR T-cell therapy lived…
Results from a multinational study found that using artificial intelligence (AI) assistance can help pathologists…
A large observational study of more than 170,000 patients with diabetes and obesity in the…
The international phase 3 DESTINY-Gastric04 clinical trial found that second-line treatment with trastuzumab deruxtecan can help…
The Ental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, has…
Welcome to Part 1 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.
Results from the international phase 3 AMPLTUDE clinical trial found that adding niraparib to abiraterone…
Small cell lung cancer (SCLC) accounts for approximately 15% of lung cancers, and most patients…
A dual-target CAR T cell therapy approach shows promise for slowing tumour growth in glioblastoma. Tumours became…